Peter de Waele
Amministratore Delegato presso Advanced Therapies Consulting Limited
Posizioni attive di Peter de Waele
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Advanced Therapies Consulting Limited | Amministratore Delegato | - | - |
Storia della carriera di Peter de Waele
Precedenti posizioni note di Peter de Waele
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELYAD ONCOLOGY SA | Direttore Tecnico/Scientifico/R&S | 01/11/2010 | - |
| Corporate Officer/Principal | 01/11/2010 | - | |
| Xcellentis NV | Direttore operativo | 01/01/2006 | 01/01/2006 |
| Fondatore | 01/01/2006 | 01/01/2006 | |
| Ghent University | Corporate Officer/Principal | 01/01/1986 | 01/01/1986 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - | - |
Formazione di Peter de Waele
| Ghent University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Belgio | 5 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| Aziende private | 3 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
| Xcellentis NV | Health Technology |
| Advanced Therapies Consulting Limited |
- Borsa valori
- Insiders
- Peter de Waele
- Esperienza
